IRCT201205279875N1已完成2 期
The comparison of effects of Filgrastim and Peg-Filgrastim in neutropenic patients
Cinnagen Drug Corporation0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 16 years（—）
- 性别
- All
入选标准
- •Patients with leukemia or solid tumor; Neutropenia due to infection or chemotherapy
- •Exclusion criteria: Patients with drug reaction to investigation drugs; Failure to refer the patients to follow up.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
已完成
1 期
The effect of filgrastim and pegfilgrastim in the treatment of fever and immune deficiencyIschemic stroke.Cerebral infarctionIRCT20130812014333N80Vice chancellor for research, Kermanshah University of Medical Sciences100
进行中（未招募）
不适用
PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.Maintenance of dose-intensityMedDRA version: 6.1Level: HLGTClassification code 10025320EUCTR2005-004646-13-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI50
进行中（未招募）
1 期
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes)CTIS2024-515275-35-00Hospices Civils De Lyon42
已完成
2 期
Comparison of the effect of two doses of filgrastim in the treatment of neutropeniaIRCT20180103038196N8Gorgan University of Medical Sciences60